Paraneoplastic dermatoses are skin lesions caused by the presence of malignant tumors, but unrelated to the direct action of the tumor and its skin metastases. Dermatologic lesions are the second most common form of paraneoplastic syndrome, immediately after endocrine manifestations. This chapter covers the main paraneoplastic dermatoses cited in the literature. Among them are acanthosis nigricans maligna, tripe palms, acquired ichthyosis, erythema gyratum repens, Bazex syndrome, acquired hypertrichosis lanuginosa, necrolytic migratory erythema, erythema gyratum repens, Leser–Trélat sign, paraneoplastic pemphigus, paraneoplastic neutrophilic dermatoses, multicentric reticulohistiocytosis, and necrobiotic xanthogranuloma. Although they are rare they are very important lesions in the practice of dermatology, since in many cases paraneoplastic dermatosis is the first manifestation of the neoplasia, enabling an earlier diagnosis of the tumor, improving its prognosis, and also, because of the parallel course with the neoplasia, helping to monitor its recurrence.
This is a preview of subscription content, log in to check access.
Thickening of the spinous layer. It is a type of epidermal hyperplasia.
Clinical condition characterized by erythematous to violaceous papulosquamous plaques arise over accrual areas.
Erythema gyratum repens
Disorder characterized by the presence of polycyclic, serpiginous erythema with scaling on its border, rapidly progressive, producing ring-shaped erythematous, concentric figures similar to a wood surface. It is highly associated with neoplasias.
A condition characterized by generalized erythema and scaling, often associated with pruritus and systemic symptoms
A benign tumor-like malformation composed of an abnormal mixture of mature cells and tissues found in areas of the body where growth occurs. It is considered a developmental error and can occur at a number of sites. Example: hemangiomas, melanocytic nevi.
Increase in density and length of the hair accepted limits of normal for age, sex, or race.
Prolonged retention of the stratum corneum, leading to the formation of fishlike scales.
Low molecular weight molecules (cytokines), important intercellular messengers, produced by leukocytes, which preferably exert their effect in other white blood cells.
State of having multiple benign tumor of smooth muscle (leiomyomas).
Sudden increase in the quantity and rapid growth in size of seborrheic keratoses.
Multiple endocrine neoplasias
Rare, inherited genetic mutational disorders whereby several endocrine glands develop benign or malignant tumors or grow excessively without forming tumors. A single gene responsible for type 1 disease has been identified. Abnormalities in a different gene have been identified in persons with types 2A and 2B disease.
A disease caused by a granulomatous inflammation that results in the presence of plaques and firm, yellowish nodules, particularly in the face.
Describes processes occurring in cell necrosis and tissue detachment.
Palmar thickening with marked palmar ridges and grooves, which exaggerate the dermatoglyphs (digital print) giving it a rough, velvety appearance.
Clinical or biochemical alterations associated with malignant neoplasias that are not directly related to the invasion of the primary tumor or its metastases.
Descriptive term that combines atrophy, telangiectasia, and hyper- or hypopigmentation that may occur in different clinical situations.
Systemic granulomatous disease of unknown cause. Papulonodular skin lesions containing a proliferation of true histiocytes (macrophages) are associated with arthritis.
Chung VQ, Moschella SL, Zembowicz A, et al. Clinical and pathologic findings of paraneoplastic dermatoses. J Am Acad Dermatol. 2006;54(5):745–62.CrossRefPubMedGoogle Scholar
Stedman TL. Dicionário médico. 25th ed. Rio de Janeiro: Guanabara Koogan; 1996. p. 945.Google Scholar
Curth HO. Skin lesions and internal carcinoma. In: Andrade R, editor. Cancer of the skin: biology, diagnosis, management. Philadelphia: Saunders; 1976.Google Scholar
Koyama S, Ikeda K, Sato M, Shibahara K, Yuhara K, et al. Transforming growth factor-alpha (TGFα)-producing gastric carcinoma with acanthosis nigricans: an endocrine effect of TGFα in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus. J Gastroenterol. 1997;32:71–7.CrossRefPubMedGoogle Scholar
Krawczyk M, Mykała-Cieśla J, Kołodziej-Jaskuła A. Acanthosis nigricans as a paraneoplastic syndrome. Case reports and review of literature. Polskie Arch Med Wewn. 2009;119:180–3.Google Scholar
Yeh JSM, Munn SE, Plunkett TA, Harper PG, Hopster DJ, et al. Coexistence of acanthosis nigricans and the sign of Leser-Trelat in a patient with gastric adenocarcinoma: a case report and literature review. J Am Acad Dermatol. 2000;42(3):57–62.Google Scholar
Pentenero M, Carrozzo M, Pagano M, Gandolfo S. Oral acanthosis nigricans, tripe palms and sign of Leser-Trélat in a patient with gastric adenocarcinoma. Int J Dermatol. 2004;43:530–2.CrossRefPubMedGoogle Scholar
Brinca A, Cardoso JC, Brites MM, Tellechea O, Figueiredo A. Florid cutaneous papillomatosis and acanthosis nigricans maligna revealing gastric adenocarcinoma. An Bras Dermatol. 2011;86:573–7.CrossRefPubMedGoogle Scholar
Zhang N, Qian Y, Feng AP. Acanthosis nigricans, tripe palms, and sign of Leser-Trélat in a patient with gastric adenocarcinoma: case report and literature review in China. Int J Dermatol. 2015;54:338–42.CrossRefPubMedGoogle Scholar
Chosidow O, Becherel PA, Piette JC, Arock M, Debre P, Frances C. Tripe palms associated with systemic mastocytosis: the role of transforming growth factor-a and efficacy of interferon-alfa. Br J Dermatol. 1998;138:698–703.CrossRefPubMedGoogle Scholar
Fink AM, Filz D, Krajnik G, Jurecka W, Ludwig H, Steiner A. Seborrhoeic keratoses in patients with internal malignancies: a case-control study with prospective accrual of patients. J Eur Acad Dermatol Venereol. 2009;23:1316–9.CrossRefPubMedGoogle Scholar
Sparsa A, Liozon E, Herrmann F, Ly K, Lebrun V, et al. Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients. Arch Dermatol. 2002 Jul;138(7):885–90.CrossRefPubMedGoogle Scholar
Wang J, Guo G, Chen G, Wu B, Lu L, Bao L. Meta-analysis of the association of dermatomyositis and polymyositis with cancer. Br J Dermatol. 2013;169:838–47.CrossRefPubMedGoogle Scholar
Ohzono A, Sogame R, Li X, Teye K, Tsuchisaka A, Numata S, Koga H, Kawakami T, Tsuruta D, Ishii N, Hashimoto T. Clinical and immunologic findings in 104 cases of paraneoplastic pemphigus. Br J Dermatol. 2015;173:1447–52.CrossRefPubMedGoogle Scholar
Nguyen VT, Ndoye A, Bassler KD, et al. Classification, clinical manifestations, and immunopathologic mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus. Arch Dermatol. 2001;137:193–206.PubMedGoogle Scholar
Porro AM, de Caetano L VN, de SN ML, MMS E. Nonclassical forms of pemphigus: pemphigus herpetiformis, IgA pemphigus, paraneoplastic pemphigus and IgG/IgA pemphigus. An Bras Dermatol. 2014;89(1):96–117.CrossRefPubMedPubMedCentralGoogle Scholar
Cohen PR, Talpaz M, Kurzrock R. Malignancy-associated Sweet’s syndrome: review of the world literature. J Clin Oncol. 1988;6:1887–97.CrossRefPubMedGoogle Scholar
Rochet NM, Chavan RN, Capel MA, Wada DA, Gibson LE. Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients. J Am Acad Dermatol. 2013;69:557–64.CrossRefPubMedGoogle Scholar
Bennett ML, Jackson JM, Jorizzo JL, Fleischer AB, White WL, Callen JP. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine. 2000;79:37–46.CrossRefPubMedGoogle Scholar
Duguid CM, O’loughlin S, Otridge B, Powell FC. Paraneoplastic pyoderma gangrenosum. Australas J Dermatol. 1993;34:17–22.CrossRefPubMedGoogle Scholar
Luz FB, Gaspar TAP, Kalil-Gaspar N, Ramos-e-Silva M. Multicentric reticulohistiocytosis. J Eur Acad Dermatol Venereol. 2001;15:524–31.CrossRefPubMedGoogle Scholar
Snow JL, Muller AS. Malignancy-associated multicentric reticulohistiocytosis: a clinical, histologic and immunophenotypic study. Br J Dermatol. 1995;133:71–6.CrossRefPubMedGoogle Scholar
Wood AJ, Wagner MVU, Abbott JJ, Gibson LE. Necrobiotic xanthogranuloma a review of 17 cases with emphasis on clinical and pathologic correlation. Arch Dermatol. 2009;145(3):279–84.CrossRefPubMedGoogle Scholar
Slee PHTJ, Waal RIF, Schagen van Leeuwen JH, Tupker RA, Timmer R, Seldenrijk CA, van Steensel MAM. Paraneoplastic hypertrichosis lanuginosa acquisita: uncommon or overlooked? Br J Dermatol. 2007;157:1087–92.CrossRefPubMedGoogle Scholar
Hegedus SI, Schorr WF. Acquired hypertrichosis lanuginose and malignancy. A clinical review and histopathologic evaluation with special attention to the “mantle” hair of Pinkus. Arch Dermatol. 1972;106:84–8.CrossRefPubMedGoogle Scholar
Weisshaar E, Weiss M, Mettang T, Yosipovitch G, Zylicz Z. Paraneoplastic itch: an expert position statement from the Special Interest Group (SIG) of the International Forum on the Study of Itch (IFSI). Acta Derm Venereol. 2015;95:261–5.CrossRefPubMedGoogle Scholar
Weisshaar E, Szepietowski JC, Darsow U, Misery L, Wallengren J, et al. European guideline on chronic pruritus. Acta Derm Venereol. 2012;92:563–81.CrossRefPubMedGoogle Scholar
Fett N, Haynes K, Propert KJ, Margolis DJ. Five-year malignancy incidence in patients with chronic pruritus: a population-based cohort study aimed at limiting unnecessary screening practices. J Am Acad Dermatol. 2014;70:651–8.CrossRefPubMedPubMedCentralGoogle Scholar
Johannesdottir SA, Farkas DK, Vinding GR, Pedersen L, Lamberg A, Sorensen HT, et al. Cancer incidence among patients with a hospital diagnosis of pruritus: a nationwide Danish cohort study. Br J Dermatol. 2014;171:839–46.CrossRefPubMedGoogle Scholar
Singer EM, Shin DB, Nattkemper LA, Benoit BM, Klein RS, Didigu CA, et al. IL-31 is produced by the malignant T-cell population in cutaneous T-cell lymphoma and correlates with CTCL pruritus. J Invest Dermatol. 2013;133:2783–27.CrossRefPubMedGoogle Scholar
Sigurdsson V, Toonstra J, Hezemans-Boer M, Van Vloten WA. Erythroderma. A clinical and follow-up study of 102 patients, with special emphasis on survival. J Am Acad Dermatol. 1996;35:53–7.CrossRefPubMedGoogle Scholar
Kurzrock R, Cohen PR. Mucocutaneous paraneoplastic manifestations of hematologic malignancies. Am J Med. 1995;99(2):207–16.CrossRefPubMedGoogle Scholar